comparemela.com

Latest Breaking News On - Dr lal path labs - Page 2 : comparemela.com

Stocks in news: HDFC, Sun Pharma, NTPC, Delta Corp and more

EXCLUSIVE: E-commerce, payment platforms to be integrated with Unified Health Interface under Ayushman Bharat, says NHA

After integration of these platforms with UHI, users can avail a large number of health services like tele-consultation with a doctor, availing services of a lab, transferring test reports or health records digitally to the doctor and paying digitally for any of the above services.

Covid-19: Testing delays a big issue in Uttar Pradesh

Covid-19: Testing delays a big issue in Uttar Pradesh SECTIONS Share Synopsis Executives working at collection centres of prominent diagnostic chains Dr Lal Path-Labs and SRL Diagnostics said they have not been collecting samples for Covid-19 testing for close to 10 days now because they have orders from the administration to not test. Uttar Pradesh chief minister Yogi Adityanath has called for scaling up RT-PCR tests to at least 1.5 lakh each day. Amid the record jump in new Covid-19 infections in Lucknow, testing for the disease in the city has been severely constrained with several private diagnostic laboratories not conducting tests or limiting their sample collection. Some pathology chains ET spoke with said they have been disallowed . Some others cited logistical bottlenecks for drastically reducing sample collection.

Dr Lal PathLab hits record high; rises over 12% in three sessions

Dr Lal Path Labs soared 6.90% to Rs 3,355.65, rising for the third straight session. On the BSE, 76,000 shares were traded in the counter compared with the average daily volume of 11,969 shares in the past one quarter. On the NSE, 20,43,052 shares were traded in the counter compared with the average daily volume of 2,72,979 in the past one quarter. The stock has risen 12.33% in three sessions from its recent closing low of Rs 2,987.25 on 7 April 2021. The stock hit a record high of Rs 3,398.95 in the intraday today. The scrip has surged 135.14% from its 52-week low of Rs 1,445.50 hit on 22 April 2020. On the technical front, the stock s RSI (relative strength index) stood at 80.658. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.

Auto stocks, ICICI Bank, Tata Motors, Tech Mahindra in focus

Auto stocks will be in focus as auto companies will start announcing monthly sales numbers for January starting from 1 February 2021. ICICI Bank reported 19.1% rise in net profit to Rs 4,939.59 crore on 3.3% increase in total income to Rs 24416.06 crore in Q3 FY21 over Q3 FY20. Net interest income (NII) increased by 16% year-on-year (YoY) to Rs 9,912 crore in Q3 FY21 from Rs 8,545 crore in Q3 FY20. Net interest margin (NIM) was at 3.67% as on 31 December 2021 as compared to 3.77% as on 31 December 2019. Tata Motors consolidated net profit surged 64.9% to Rs 3,222.21 crore on 5.4% rise in net sales to Rs 74,878.98 crore in Q3 December 2020 over Q3 December 2019. Consolidated profit before tax (PBT) soared 208.70% to Rs 4,167.39 crore in Q3 December 2020 as against Rs 1,349.92 crore in Q3 December 2019. Current tax expense for the quarter jumped 22.7% to Rs 675.45 crore as against Rs 550.33 crore in Q3 December 2019.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.